PROPONENT BIOTECH GMBH has a total of 41 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and environmental technology are BOMAC LAB LTD, 442 VENTURES LLC and Hennepin Life Sciences.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 4 | |
#5 | Australia | 3 | |
#6 | Brazil | 3 | |
#7 | Chile | 3 | |
#8 | China | 3 | |
#9 | Republic of Korea | 3 | |
#10 | Mexico | 3 | |
#11 | Singapore | 3 | |
#12 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Ernst Bettina | 32 |
#2 | Bettina Ernst | 9 |
Publication | Filing date | Title |
---|---|---|
CN109152755A | Carboxylic acid for children's early stage application | |
KR20190008235A | Carboxylic acids for treating / preventing skin diseases | |
CA3020485A1 | Carboxylic acid for treating/preventing nasal congestion | |
EP3207933A1 | Uses of polyfructans | |
WO2014053592A1 | Esters of short chains fatty acids for use in the treatment of immunogenic disorders | |
WO2012131069A1 | Short chain fatty acids and their derivatives for use in treatment immunogenic disorders |